-
Your RFQ cart is empty!
Evogliptin Tartarate
Venkatasai is a leading provider of pharmaceutical reference standards, specializing in the supply of high-purity Evogliptin Tartarate reference materials. Our portfolio includes both pharmacopeial and non-pharmacopeial impurities, metabolites, stable isotope-labeled compounds, and nitrosamine derivatives (N-NO products). These reference standards play a crucial role in pharmaceutical R&D, aiding in formulation development, ANDA/DMF submissions, quality control, method validation, stability studies, and impurity profiling—including the identification and assessment of potentially genotoxic impurities.
Each Evogliptin Tartarate-related product is rigorously characterized and delivered with a detailed Certificate of Analysis (COA) and comprehensive analytical data to ensure regulatory compliance. Upon request, we also offer EP/USP traceable standards. To maintain the highest quality standards, all materials are subject to periodic re-testing and continuous quality monitoring.
Evogliptin Tartarate is a medication used to manage high blood pressure and chest pain. It acts as both an alpha- and beta-adrenergic receptor blocker, making it effective for treating hypertension, angina, and conditions involving excessive sympathetic nervous system activity.
Evogliptin Tartarate
Evogliptin Impurity S1
Evogliptin Impurity S2
Evogliptin Impurity S3
Evogliptin Impurity R15
Evogliptin Impurity R6
Evogliptin Impurity R7
Evogliptin Impurity R5
Evogliptin Impurity
Evogliptin Impurity 1
Evogliptin Impurity 2
Evogliptin Impurity 3
